Launch a GLP-1 brand in 5 days.
GLP-1 is the most competitive category in telehealth and the one where operational detail decides margin. Titration means the dose changes; cold chain means the shipment is fragile; and a program that bills on a calendar rather than on the ship date will leak money every month from cycle four onward.
- Compounded semaglutide and tirzepatide, injectable and oral
- Cold-chain qualified pharmacies, routed per SKU and state
- Titration schedules your providers define, billed on ship date
- Check-ins gate every refill, so the clinical loop actually closes
How a GLP-1 program runs
Weight management is a twelve-month relationship, not a purchase. Each stage below writes to the same patient record, because month eight is where this business is actually decided.
Condition-specific intake
BMI, comorbidities, medication history, thyroid and pancreatitis history, allergies and consent. Written for this therapy, not adapted from a generic form.
Eligibility screening at intake
Contraindications and BMI thresholds evaluate inside the form. An ineligible visitor stops before checkout rather than after a card is charged.
Provider review
A clinician licensed in the patient's state reviews the submitted intake and decides. No appointment, no scheduling, no call. Where a state will not permit an async initial prescription, the intake screens that patient out rather than booking them.
Cold-chain pharmacy routing
The prescription transmits to a compounding pharmacy qualified for temperature-sensitive shipping and licensed into that state.
Titration and check-ins
No refill ships until the patient files a check-in on progress and side effects. The provider then decides the next dose, and the invoice follows whatever the pharmacy actually sends.
Portal tracking on your domain
Shipments, doses remaining, next check-in and payment methods, under your brand from first order through month twelve.
Titration is a billing problem, not just a clinical one
This is the detail that separates a GLP-1 program that compounds from one that quietly bleeds. The dose changes over the patient's life, and the invoice has to follow it.
- Pricing is aware of which dose step a patient is on and how often they are billed, monthly or quarterly.
- Titration steps follow the protocol you define with your providers, not a fixed ladder.
- The charge goes out when the pharmacy hands the parcel over, not on a date picked in advance.
- What the patient reported at check-in reaches the clinician before they approve the next cycle.
- The in-house rebill engine recovers 0.5 to 1% of billings per cycle through smart retries and card account updater coverage.
- Multi-month plans are billed as one-time charges on ship events, so a paused patient is not billed for a shipment that never left.
Clinical and regulatory shape of the category
| Visit type | Asynchronous throughout. The patient submits an intake and a licensed provider reviews it. State eligibility is screened at intake. |
|---|---|
| Typical eligibility | BMI at or above 27, or at or above 25 with a qualifying comorbidity. Screened inside the intake. |
| Refill cadence | Four or eight week review cycles during titration, extending to roughly twelve weeks once the patient reaches steady-state dosing. |
| Labs | Commonly ordered but not usually a gate on the first fill, unless the intake surfaces an indication. |
| Shipping | Cold chain for injectables. Routing only selects pharmacies qualified for temperature-sensitive transit. |
| Scheduling | Compounded semaglutide and tirzepatide are not controlled substances, so there is no DEA schedule constraint on the category. |
Oversight is wired in, not bolted on
Prescriptions are involved, so clinical oversight is not a setting you switch on. It is wired into the workflow, and there is no configuration in which it is absent.
Provider review the platform enforces
Nothing is prescribed until a clinician holding a licence in that patient's state signs off. There is no path through the software that reaches a pharmacy without it.
State rules in the routing layer
Which questions get asked, which clinician picks up the case and which pharmacy fills it are all decided by where the patient is sitting. Texas and California can run as different programs without you maintaining two of anything.
An audit trail you can query
Every intake version, clinical decision, script and pharmacy handoff is written to the patient record and stays queryable. When someone asks what happened in March, you answer it in a minute.
GLP-1 operators ask us
Yes, through licensed compounding pharmacies where clinically appropriate and permitted, prescribed by a provider licensed in the patient's state. PharmaBro routes to 503A and 503B partners qualified for the compound and the state, with cold-chain capability for injectables.
Put your weight-management brand on clinical rails
Cold-chain fulfillment, dose-aware billing, and payments into a Stripe account you own. Live in 5 days.